Nuwellis (NUWE) FCF Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -625.00 |
| Dec 31, 2025 | 2,186.00 |
| Sep 30, 2025 | -2,457.00 |
| Jun 30, 2025 | 1,140.00 |
| Mar 31, 2025 | -6,743.00 |
| Dec 31, 2024 | 3,796.00 |
| Sep 30, 2024 | 2,290.00 |
| Jun 30, 2024 | 2,906.00 |
| Mar 31, 2024 | -4,913.00 |
| Dec 31, 2023 | 5,705.00 |
| Sep 30, 2023 | 9,197.00 |
| Jun 30, 2023 | 7,954.00 |
| Mar 31, 2023 | -20,060.00 |
| Dec 31, 2022 | 2,429.00 |
| Sep 30, 2022 | 1,966.00 |
| Jun 30, 2022 | 7,581.00 |
| Mar 31, 2022 | 49.00 |
| Dec 31, 2021 | -974.00 |
| Sep 30, 2021 | -8,947.00 |
| Jun 30, 2021 | 12,798.00 |
| Mar 31, 2021 | -11,229.00 |
| Dec 31, 2020 | 6,727.00 |
| Sep 30, 2020 | -6,045.00 |
| Jun 30, 2020 | 16,011.00 |
| Mar 31, 2020 | -4,145.00 |
| Dec 31, 2019 | 433.00 |
| Sep 30, 2019 | -5,751.00 |
| Jun 30, 2019 | 16,371.00 |
| Mar 31, 2019 | -22,459.00 |
| Dec 31, 2018 | 6,834.00 |
| Sep 30, 2018 | 6,803.00 |
| Jun 30, 2018 | 17,211.00 |
| Mar 31, 2018 | -10,557.00 |
| Dec 31, 2017 | -4,523.00 |
| Sep 30, 2017 | 13,467.00 |
| Jun 30, 2017 | -29,587.00 |
| Mar 31, 2017 | 18,762.00 |
| Dec 31, 2016 | 46,345.00 |
| Mar 31, 2015 | -905,989.00 |
| Dec 31, 2014 | 630,056.00 |